ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2020 and Provide a Corporate Strategic Update
Conference Call to be Held on May 14, 2020
Get Alerts THMO Hot Sheet
Join SI Premium – FREE
RANCHO CORDOVA, Calif., May 7, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2020 and provide a corporate strategic update on Thursday, May 14, 2020 after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.
To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.
A replay of the call will be available until June 4 and can be accessed by dialing 1-877-344-7529 (domestic), 1-412-317-0088 (international) or 1-855-669-9658 (Canada) and referencing access code 10142864. The webcast will be available for three months.
About ThermoGenesis Holdings, Inc.ThermoGenesis Holdings, Inc., develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automated manufacturing process for the emerging CAR-T immunotherapy market.
In response to the global COVID-19 pandemic, the Company is marketing a SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit in accordance with Section IV.D. of the "Policy for Diagnostic Tests for Coronavirus Disease – 2019 during the Public Health Emergency," issued by the U.S. Food and Drug Administration on March 16, 2020.
For more information about ThermoGenesis, please visit: www.ThermoGenesis.com.
For more information about the Company's Rapid COVID-19 Test, please visit: www.thermogenesis.com/covid-19-test-kit/ or click here to view the listing on the FDA website
Company Contact:Wendy Samford916-858-5191[email protected]
Investor Contact:Paula Schwartz, Rx Communications917-322-2216[email protected]
View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-first-quarter-ended-march-31-2020-and-provide-a-corporate-strategic-update-301054706.html
SOURCE ThermoGenesis Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- 36Kr Holdings Inc. Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
- New Oriental to Report Third Quarter 2024 Financial Results on April 24, 2024
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!